Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.

O'Neill JO, Bott-Silverman CE, McRae AT 3rd, Troughton RW, Ng K, Starling RC, Young JB.

Am Heart J. 2005 Feb;149(2):363-9.

PMID:
15846278
2.

A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study.

Kazanegra R, Cheng V, Garcia A, Krishnaswamy P, Gardetto N, Clopton P, Maisel A.

J Card Fail. 2001 Mar;7(1):21-9.

PMID:
11264546
3.

NT-ProBNP in acute heart failure: correlation with invasively measured hemodynamic parameters during recompensation.

Knebel F, Schimke I, Pliet K, Schattke S, Martin S, Borges AC, Baumann G.

J Card Fail. 2005 Jun;11(5 Suppl):S38-41.

PMID:
15948099
4.

Only large reductions in concentrations of natriuretic peptides (BNP and NT-proBNP) are associated with improved outcome in ambulatory patients with chronic heart failure.

Miller WL, Hartman KA, Grill DE, Burnett JC Jr, Jaffe AS.

Clin Chem. 2009 Jan;55(1):78-84. doi: 10.1373/clinchem.2008.108928. Epub 2008 Nov 21.

5.

Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.

Rudiger A, Gasser S, Fischler M, Hornemann T, von Eckardstein A, Maggiorini M.

Crit Care Med. 2006 Aug;34(8):2140-4.

PMID:
16763507
6.

B-type natriuretic peptide (BNP) is more sensitive to rapid hemodynamic changes in acute heart failure than N-terminal proBNP.

Mair J, Falkensammer G, Poelzl G, Hammerer-Lercher A, Griesmacher A, Pachinger O.

Clin Chim Acta. 2007 Apr;379(1-2):163-6. Epub 2007 Jan 3.

PMID:
17258185
7.

In critically ill patients, B-type natriuretic peptide (BNP) and N-terminal pro-BNP levels correlate with C-reactive protein values and leukocyte counts.

Rudiger A, Fischler M, Harpes P, Gasser S, Hornemann T, von Eckardstein A, Maggiorini M.

Int J Cardiol. 2008 May 7;126(1):28-31. Epub 2007 May 2.

PMID:
17477984
8.

B-type natriuretic peptide levels in obese patients with advanced heart failure.

Horwich TB, Hamilton MA, Fonarow GC.

J Am Coll Cardiol. 2006 Jan 3;47(1):85-90. Epub 2005 Dec 15.

9.

Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study.

Brenden CK, Hollander JE, Guss D, McCullough PA, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R, Maisel AS; REDHOT Investigators..

Am Heart J. 2006 May;151(5):1006-11.

PMID:
16644322
10.

Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.

Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.

J Am Coll Cardiol. 2008 Jul 22;52(4):266-72. doi: 10.1016/j.jacc.2008.03.050.

11.

Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.

Campana C, Pasotti M, Klersy C, Alessandrino G, Albertini R, Magrini G, Ghio S, Tavazzi L.

J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):671-6. doi: 10.2459/JCM.0b013e328329346a.

PMID:
19444135
12.

Heart failure in patients with aortic stenosis: clinical and prognostic significance of carbohydrate antigen 125 and brain natriuretic peptide measurement.

Antonini-Canterin F, Popescu BA, Popescu AC, Beladan CC, Korcova R, Piazza R, Cappelletti P, Rubin D, Cassin M, Faggiano P, Nicolosi GL.

Int J Cardiol. 2008 Aug 29;128(3):406-12. Epub 2007 Jul 26.

PMID:
17662495
13.

B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure.

Iwanaga Y, Nishi I, Furuichi S, Noguchi T, Sase K, Kihara Y, Goto Y, Nonogi H.

J Am Coll Cardiol. 2006 Feb 21;47(4):742-8. Epub 2006 Jan 26.

14.

Serial biomarker measurements in ambulatory patients with chronic heart failure: the importance of change over time.

Miller WL, Hartman KA, Burritt MF, Grill DE, Rodeheffer RJ, Burnett JC Jr, Jaffe AS.

Circulation. 2007 Jul 17;116(3):249-57. Epub 2007 Jun 25.

15.
16.

B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.

Valle R, Aspromonte N, Giovinazzo P, Carbonieri E, Chiatto M, di Tano G, Feola M, Milli M, Fontebasso A, Barro S, Bardellotto S, Milani L.

J Card Fail. 2008 Apr;14(3):219-24. doi: 10.1016/j.cardfail.2007.10.009.

PMID:
18381185
17.

Rapid assay brain natriuretic peptide and troponin I in patients hospitalized with decompensated heart failure (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial).

Shah MR, Hasselblad V, Tasissa G, Christenson RH, Binanay C, O'Connor CM, Ohman EM, Stevenson LW, Califf RM.

Am J Cardiol. 2007 Nov 1;100(9):1427-33. Epub 2007 Aug 21.

PMID:
17950802
19.

Effects of growth hormone treatment on B-type natriuretic peptide as a marker of heart failure in adults with growth hormone deficiency.

Wallaschofski H, Saller B, Spilcke-Liss E, Lerch MM, Lohmann T, Eigenthaler M.

Horm Metab Res. 2006 Oct;38(10):656-61.

PMID:
17075774
20.

Pro-B-type natriuretic peptide levels in acute decompensated heart failure.

Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.

J Am Coll Cardiol. 2008 May 13;51(19):1874-82. doi: 10.1016/j.jacc.2007.12.051.

Supplemental Content

Support Center